Product Information
DULOXETINE HCL DR 40 MG CAP is a generic product labeled by Lupin Pharmaceuticals Inc., priced at $1.2439 per EA under NDC 68180029706. Its NADAC has been published 550 times since Mar 23, 2016.
FDA first approved this application on Dec 11, 2013. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
40 mg/1
Manufacturer
Lupin Pharmaceuticals Inc.NDC
68180029706
Classification
Generic
Dosage Form
CAPSULE, DELAYED RELEASE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
DULOXETINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA090694FDA Approved
12/11/2013
TE Code
AB
On Market Since
5/25/2015
Pharmacological Classes
Price Statistics
The NADAC for DULOXETINE HCL DR 40 MG CAP has been published 550 times since Mar 23, 2016, and over the history we have for it it has declined 61.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.2439 per EA |
|---|---|
| All-time high | $3.5966 (Jan 11, 2017) |
| All-time low | $0.9547 (Jul 17, 2024) |
| 52-week high | $1.3767 |
| 52-week low | $1.0466 |
| Median price | $2.1703 |
| Average price | $2.2033 |
| Largest weekly change | +46.1% (Aug 21, 2024) |
| Weeks tracked | 550 |
| Tracking since | Mar 23, 2016 |
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Lupin Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Duloxetine market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Serotonin and Norepinephrine Reuptake Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of DULOXETINE HCL DR 40 MG CAP?
The current National Average Drug Acquisition Cost (NADAC) for DULOXETINE HCL DR 40 MG CAP, manufactured by Lupin Pharmaceuticals Inc., is $1.2439 per EA (NDC 68180029706), effective Sep 30, 2026.
How has the price of DULOXETINE HCL DR 40 MG CAP changed over time?
Over the history we have for it, the NADAC for DULOXETINE HCL DR 40 MG CAP has declined 61.1%. It has been tracked across 550 weekly CMS publications since Mar 23, 2016.
What are the highest and lowest recorded NADAC prices for DULOXETINE HCL DR 40 MG CAP?
Since Mar 23, 2016, the NADAC for DULOXETINE HCL DR 40 MG CAP has ranged from a low of $0.9547 (Jul 17, 2024) to a high of $3.5966 (Jan 11, 2017), with a median of $2.1703 per EA.
Are there cheaper alternatives to DULOXETINE HCL DR 40 MG CAP?
4 manufacturers publish a NADAC-priced product with the same active ingredient and strength as DULOXETINE HCL DR 40 MG CAP in a comparable dosage form, but none are currently priced below it.
Who manufactures DULOXETINE HCL DR 40 MG CAP?
DULOXETINE HCL DR 40 MG CAP (NDC 68180029706) is labeled by Lupin Pharmaceuticals Inc., and CMS classifies it as a generic product.